SCHEMBL6154089

SCHEMBL6154089

Oc1ccc(-c2nnc(Nc3ccc(Br)c(Cl)c3)s2)cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 4/20 0.51
GUSB P08236 3/20 0.50
MEN1 O00255 2/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 2/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
HPN P05981 1/20 0.45
BLM P54132 5/20 0.42
S1PR1 P21453 1/20 0.41
WRN Q14191 2/20 0.39
HDAC6 Q9UBN7 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
DNMT1 P26358 1/20 0.38
HTT P42858 1/20 0.38
DUSP3 P51452 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6156992 0.81 MEN1 (0.64) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6154986 0.80 GUSB (0.47) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6155696 0.79 GUSB (0.49) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6154727 0.76 GUSB (0.61) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6155606 0.76 GUSB (0.61) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6155440 0.76 GUSB (0.52) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6156141 0.75 GUSB (0.48) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL6153921 0.74 NOTUM (0.53) GUSBMEN1POLBKMT2ACTDSP1
SCHEMBL27879285 0.74 NPC1 (0.51) SNCAMEN1POLBKMT2AS1PR1
SCHEMBL6155161 0.72 GUSB (0.60) GUSBMEN1POLBKMT2ACTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SNCA 3218/4885GUSB 2466/4885MEN1 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.